TheEdgeResearch
Home / Stocks / NAYA

NAYA Biosciences, Inc. (NAYA)

NASDAQ Healthcare Medical - Devices
$2.20 ▲ +8.37%
Market Cap
$1.5M
Sector
Healthcare
Industry
Medical - Devices
Beta
2.04
52-Wk Range
1.38-17.04
CEO
Steven M. Shum
Country
US
Currency
USD

NAYA Biosciences, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Sarasota, US. The stock last traded at $2.20, up 8.37% on the session, giving a market capitalisation of $1.5M. On trailing twelve-month figures it carries a trailing P/E of -0.07, a net margin of -139.3%. Its beta of 2.04 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.07
Price / Sales
0.22
Price / Book
0.05
EV / EBITDA
-1.49
Gross margin
44.0%
Operating margin
-124.4%
Net margin
-139.3%
Return on equity
Debt / equity
0.78
Current ratio
0.07
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Market
Employees
30
IPO date
2020-11-02
Headquarters
Sarasota, US
About NAYA Biosciences, Inc.

INVO Bioscience operates as a medical device company, focusing on the development and provision of tools and solutions for diagnosing infertility. Their primary innovation is INVOcell, a unique reproductive technology designed to allow both fertilization and the early development of an embryo to happen inside the woman's own body.

Comparable companies

NAYA Biosciences, Inc. is most often compared with the following Healthcare names:

AVGRAXDXCMAXCUTRNBSEONCSQONCTSAVAWSIENTMBR
More research on NAYA
NAYA technical analysis NAYA TheEdge Score Compare against peers
Open full interactive analysis & DCF →